The presence of CYP51A1 mutations in patients with congenital cataracts—often accompanied by hepatic or neurological symptoms—suggests its dual role in ocular development and systemic homeostasis. The gene discussed is CYP51A1; the disease is early-onset non-syndromic cataract.